SLC3A2 and lung adenocarcinoma: IGF2BP3 could stabilize a spectrum of anti-ferroptosis mRNA, including glutathione peroxidase 4 (GPX4), solute carrier family 3 member 2 (SLC3A2), acyl-CoA synthetase long chain family member 3 (ACSL3), and ferritin heavy chain 1 (FTH1), to inhibit ferroptosis in lung adenocarcinoma cells 57.